Biofrontera Ag Asset Turnover Ratio (BFRA), as of fourth quarter 2018, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Biofrontera Ag  (BFRA)
 

Biofrontera Ag Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Biofrontera Ag asset turnover ratio, the ability of Biofrontera Ag's assets to generate revenue in the fourth quarter 2018, increased sequentially to 0.32 in the fourth quarter (Dec 31 2018), yet the ratio remained below the average, as BFRA's position remain challenging.

Within sector 100 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2018 compared to the preceding quarter from 0 to 2343.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BFRA Asset Turnover Ratio (Dec 31 2018)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2017)
IV. Quarter
Y / Y Asset Change 46.64 % 33.22 % 59.91 % 118.52 % -40.31 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.32 - - - -
BFRA's Total Ranking # 2343 # 0 # 0 # 0 # 0
Seq. Asset Change 27.9 % -16.69 % -26.82 % 88.05 % 16.2 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 101
Healthcare Sector # 250
Overall Market # 2343

Asset Turnover Ratio Statistics
High Average Low
6.64 6.64 6.64
(Dec 31 2018)  




BFRA Company Profile • Back to BFRA Efficiency Comparisons • Compare BFRA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2018, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2018 Assets at quarter ending Dec 31 2018
Vericel Corporation  0.87 $ 90.857  Millions$ 104.438  Millions
Alimera Sciences Inc  0.87 $ 46.970  Millions$ 54.066  Millions
Nevro Corp   0.86 $ 387.289  Millions$ 452.225  Millions
Abiomed Inc   0.86 $ 736.787  Millions$ 860.674  Millions
Community Health Systems Inc   0.85 $ 14,155.000  Millions$ 16,608.250  Millions
Select Medical Holdings Corp  0.85 $ 5,081.258  Millions$ 5,969.472  Millions
Meridian Bioscience Inc   0.84 $ 212.768  Millions$ 252.441  Millions
Encompass Health Corporation  0.84 $ 4,277.300  Millions$ 5,083.975  Millions
Pacific Health Care Organization Inc  0.84 $ 6.797  Millions$ 8.109  Millions
Dexcom Inc   0.84 $ 1,031.600  Millions$ 1,233.650  Millions
Carlisle Companies Incorporated  0.83 $ 4,479.500  Millions$ 5,403.400  Millions
Kamada Ltd   0.83 $ 114.469  Millions$ 138.116  Millions
Eagle Pharmaceuticals inc   0.83 $ 213.312  Millions$ 257.656  Millions
Lantheus Holdings Inc   0.83 $ 343.374  Millions$ 414.760  Millions
Exelixis Inc   0.83 $ 853.826  Millions$ 1,033.181  Millions
Antares Pharma Inc   0.83 $ 63.554  Millions$ 77.022  Millions
Msa Safety Inc  0.82 $ 1,358.104  Millions$ 1,651.256  Millions
American Renal Associates Holdings Inc   0.82 $ 805.776  Millions$ 981.800  Millions
Xtant Medical Holdings Inc   0.82 $ 72.203  Millions$ 88.315  Millions
Nanostring Technologies Inc   0.82 $ 106.732  Millions$ 130.609  Millions
Masimo Corp  0.82 $ 858.289  Millions$ 1,051.888  Millions
Tenet Healthcare Corp  0.81 $ 18,313.000  Millions$ 22,550.250  Millions
Caredx Inc   0.80 $ 76.569  Millions$ 95.244  Millions
Edap Tms Sa  0.80 $ 43.885  Millions$ 54.901  Millions
Intersect Ent Inc   0.79 $ 108.472  Millions$ 136.858  Millions
Rti Surgical Holdings Inc   0.79 $ 280.855  Millions$ 354.843  Millions
Cardax Inc   0.79 $ 1.511  Millions$ 1.909  Millions
Novocure Limited  0.78 $ 248.069  Millions$ 317.165  Millions
Resmed Inc   0.77 $ 2,454.643  Millions$ 3,182.398  Millions
Haemonetics Corporation  0.76 $ 951.836  Millions$ 1,245.389  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.